Kovarik A, Lu P J, Peat N, Morris J, Taylor-Papadimitriou J
Epithelial Cell Biology Laboratory, Imperial Cancer Research Fund, P. O. Box 123, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom.
J Biol Chem. 1996 Jul 26;271(30):18140-7. doi: 10.1074/jbc.271.30.18140.
In this report, we have analyzed the function of two Sp1 sites present in the epithelium-specific MUC1 promoter. Using promoter-reporter gene (CAT) constructs, we found that mutagenesis of either of the Sp1 binding motifs at -576/-568 and -99/-90, reduced transcription in MUC1-expressing epithelial cell lines. However, abolition of the binding site at -99/-91 by mutagenesis also resulted in increased transcriptional activity in non-epithelial cell lines, suggesting involvement of the site in tissue-specific expression. In vitro binding assays revealed a novel binding motif at -101/-89 (AGGGGGCGGGGTT), which overlaps but differs from the Sp1 consensus motif by having an adenine residue in the 5'-flanking sequence. The 5'-flanking sequence appeared to be important for binding of an Sp1-unrelated factor (SpA) but not for binding of Sp1. Site-directed mutagenesis of the motif into a site able to bind Sp1, but unable to bind SpA, resulted in an increased level of transcription of the CAT reporter gene in all cell lines tested, suggesting a repressive effect of the novel factor on transcription. The ratio between the Sp1 and SpA binding activity in nuclear extracts correlated with both promoter activity and the levels of endogenous transcription in different breast cancer cell lines. Our results are consistent with the idea that the relative activities of the two factors may be involved in the up-regulation of expression of the MUC1 gene seen in breast and other carcinomas.
在本报告中,我们分析了上皮特异性MUC1启动子中存在的两个Sp1位点的功能。使用启动子-报告基因(CAT)构建体,我们发现位于-576/-568和-99/-90的Sp1结合基序中的任何一个发生诱变,都会降低MUC1表达上皮细胞系中的转录。然而,通过诱变消除-99/-91处的结合位点也导致非上皮细胞系中转录活性增加,表明该位点参与组织特异性表达。体外结合试验揭示了位于-101/-89(AGGGGGCGGGGTT)的一个新的结合基序,它与Sp1共有基序重叠但不同,因为在5'侧翼序列中有一个腺嘌呤残基。5'侧翼序列似乎对Sp1无关因子(SpA)的结合很重要,但对Sp1的结合不重要。将该基序定点突变为能够结合Sp1但不能结合SpA的位点,导致在所有测试的细胞系中CAT报告基因的转录水平增加,表明新因子对转录有抑制作用。核提取物中Sp1和SpA结合活性的比率与不同乳腺癌细胞系中的启动子活性和内源性转录水平相关。我们的结果与以下观点一致,即这两种因子的相对活性可能参与了在乳腺癌和其他癌症中所见的MUC1基因表达上调。